日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Engineered phage with antibacterial CRISPR-Cas selectively reduce E. coli burden in mice

经基因工程改造的噬菌体利用抗菌CRISPR-Cas系统选择性地降低小鼠体内大肠杆菌的数量。

Yilmaz Emre Gencay #,Džiuginta Jasinskytė #,Camille Robert #,Szabolcs Semsey #,Virginia Martínez #,Anders Østergaard Petersen #,Katja Brunner,Ana de Santiago Torio,Alex Salazar,Iszabela Cristiana Turcu,Melissa Kviesgaard Eriksen,Lev Koval,Adam Takos,Ricardo Pascal,Thea Staffeldt Schou,Lone Bayer,Tina Bryde,Katja Chandelle Johansen,Emilie Glad Bak,Frenk Smrekar,Timothy B Doyle,Michael J Satlin,Aurelie Gram,Joana Carvalho,Lene Jessen,Björn Hallström,Jonas Hink,Birgitte Damholt,Alice Troy,Mette Grove,Jasper Clube,Christian Grøndahl,Jakob Krause Haaber,Eric van der Helm,Milan Zdravkovic,Morten Otto Alexander Sommer

Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates

在测试耐甲氧西林金黄色葡萄球菌分离株的挑战性集合时对修订的头孢洛林纸片扩散断点的评估

Helio S Sader, Paul R Rhomberg, Timothy B Doyle, Robert K Flamm, Rodrigo E Mendes